# Kefazolin Versus Kefazolin Plus Metronidazole to Reduce Postpartum Infection

> **NCT04792710** · PHASE4 · UNKNOWN · sponsor: **University of Pretoria** · enrollment: 1000 (estimated)

## Conditions studied

- Prevention of Postpartum Sepsis

## Interventions

- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT04792710
- **Lead sponsor:** University of Pretoria
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-08
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04792710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04792710, "Kefazolin Versus Kefazolin Plus Metronidazole to Reduce Postpartum Infection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04792710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*